Cited 0 times in
Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 홍민희 | - |
dc.date.accessioned | 2021-12-28T17:50:51Z | - |
dc.date.available | 2021-12-28T17:50:51Z | - |
dc.date.issued | 2021-09 | - |
dc.identifier.issn | 2211-9132 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/187295 | - |
dc.description.abstract | Kidney injury caused by anticancer agents is a common problem that can interfere with and affect the dose intensity of anticancer therapy, thus restricting patient survival. Recent advances in targeted and immunotherapeutic agents have transformed the landscape of medical oncology, and these agents have been widely employed in clinical practice. While typically associated with favorable toxicity profiles, several novel anticancer drugs present distinctive nephrotoxicities. It remains urgent to closely monitor renal injuries associated with these agents, and medical practitioners should be familiar with general principles for managing nephrotoxicity associated with novel cancer drugs. This review provides an in-depth investigation of the literature and guidelines regarding the prevalence, clinical presentations, mechanisms, and management of nephrotoxicity for each drug. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Elsevier Korea | - |
dc.relation.isPartOf | KIDNEY RESEARCH AND CLINICAL PRACTICE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | Nephrotoxicity of cancer therapeutic drugs: Focusing on novel agents | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Min Hee Hong | - |
dc.identifier.doi | 10.23876/j.krcp.21.037 | - |
dc.contributor.localId | A04393 | - |
dc.relation.journalcode | J01942 | - |
dc.identifier.eissn | 2211-9140 | - |
dc.identifier.pmid | 34233435 | - |
dc.subject.keyword | Acute kidney injury | - |
dc.subject.keyword | Immune checkpoint inhibitors | - |
dc.subject.keyword | Molecularly targeted therapy | - |
dc.subject.keyword | Neoplasms | - |
dc.subject.keyword | Renal insufficiency | - |
dc.contributor.alternativeName | Hong, Min Hee | - |
dc.contributor.affiliatedAuthor | 홍민희 | - |
dc.citation.volume | 40 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 344 | - |
dc.citation.endPage | 354 | - |
dc.identifier.bibliographicCitation | KIDNEY RESEARCH AND CLINICAL PRACTICE, Vol.40(3) : 344-354, 2021-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.